Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Hermansky-Pudlak Syndrome Clinical Presentation

  • Author: Natalio J Izquierdo, MD; Chief Editor: Hampton Roy, Sr, MD  more...
 
Updated: May 02, 2014
 

History

Past ocular history in patients with Hermansky-Pudlak syndrome should include the following:

  • Photophobia
  • Previous eyeglasses, bifocals, eyeglasses tints, low vision aids
  • Amblyopia therapy
  • Involuntary eye movements (nystagmus)
  • Eye deviations and
  • Strabismus surgery

Past systemic history in patients with Hermansky-Pudlak syndrome should include the following:

  • Bleeding diathesis: The most important questions when evaluating a patient with oculocutaneous albinism (OCA) are as follows: Do you bruise easily? Does your child bruise easily? Ask about aspirin and its derivatives intake.
  • The review of systems should include pulmonary symptoms associated to pulmonary fibrosis, such as dyspnea upon exertion, a history of previous pulmonary function tests, and steroid therapy.
  • Evaluate symptoms associated with colitis, such as abdominal pain, diarrhea, upper and lower gastrointestinal bleeding, and previous intestinal surgery.
  • Female patients with the syndrome should be asked about menometrorrhagia, abnormal uterine bleeding, complications during labor, cesarean delivery, and/or gynecologic surgery.
  • A history of sun exposure, sunblock application, skin biopsies, and malignancies should be obtained.

The family history of patients with Hermansky-Pudlak syndrome should include the following: nationality, parental consanguinity, and incidence of HPS in other family members.

Next

Physical

A wide ocular phenotypic variety exists in patients with Hermansky-Pudlak syndrome. Ocular findings in these patients include the following:[8, 9, 10]

  • Poor visual acuity: Best-corrected visual acuity in patients with Hermansky-Pudlak syndrome ranges from 20/60 to 20/400 in the Snellen chart.
  • Refractive errors that range from high myopia to hyperopia may be present. With the rule astigmatism is most common in patients with the syndrome.
  • Strabismus: Patients with both horizontal and vertical eye deviations have been reported. The most common types of strabismus found in patients with the syndrome are esotropia and exotropia.
  • Patients with Hermansky-Pudlak syndrome have congenital nystagmus. Periodic alternating nystagmus is most prevalent in patients with the syndrome. A variety of amplitudes and frequencies have beenreported.
  • Patients with Hermansky-Pudlak syndrome have several anterior segment abnormalities, including prominent Schwalbe line, iris transillumination, and presenile cataracts. Iris transillumination varies from almost total transillumination (pigment found at the collarette) to minimal peripheral transillumination (mostly in patients with HPS type 3).
  • Patients with Hermansky-Pudlak syndrome have foveal hypoplasia. Macular transparency (grading of choroidal vessels visibility) ranges from transparent to opaque. All patients have albinotic mid periphery. Vascular architecture varies.
  • Previous studies report that patients with Hermansky-Pudlak syndrome have poor binocular vision.
  • Studies show that approximately 50% of patients with Hermansky-Pudlak syndrome have color vision defects upon HRR pseudoisochromatic plates testing.
  • Visual-evoked potentials show excessive decussation of optic nerve fibers.
  • Optical coherence tomography in patients with albinism shows that patients with OCA (all types included) have thicker foveas than the general population. This may be due to absence of a foveal pit as part of foveal hypoplasia in patients with OCA. Conversely, patients with OCA have lower macular volumes than the general population. This finding is compatible with loss of retinal nuclear layers in patients with OCA.

Patients with Hermansky-Pudlak syndrome have a wide variety of phenotypic skin findings.

  • Hair color varies from light blonde to dark brown. Hair and skin pigmentation is darker in patients with HPS type 3. The latter have brown hair and iris color.
  • Skin freckles, lentigines, actinic keratosis, and premalignant and malignant skin lesions may also be present in sun exposed areas.

Patients with Hermansky-Pudlak syndrome have several systemic findings:[11, 12, 13, 14]

  • Enamel hypoplasia
  • Since patients with Hermansky-Pudlak syndrome have bleeding tendencies, inspect lower extremities for ecchymosis.
  • Patients should have a pneumologic evaluation, since more than 50% of patients with Hermansky-Pudlak syndrome have pulmonary fibrosis. Auscultate patients for wheezing.
Previous
Next

Causes

HPS is a group of autosomal recessive disorders. Therefore, consanguinity and geographical isolation increases the risk of affected offspring. Pseudodominance has been reported in the northwestern quarter of Puerto Rico, because of patients with the syndrome who marry carriers of the HPS genes in geographically isolated regions.

  • Seven genes may lead to HPS in humans. Fukai and coworkers identified an HPS gene, located in chromosome region 10q23.1-23.3 by using a positional cloning approach.[15] Genetic analysis of Puerto Rican patients identified a 16-base pair duplication/frameshift within exon 15. This results in a frameshift at codon Pro 496. This gene is called the HPS-1 gene.
  • Puerto Rican patients with HPS type 3 have all been homozygous for a 3,904-bp deletion in the HPS-3 gene, as described by Anikster and coworkers.[16]
  • However, further studies have shown evidence for locus heterogeneity in Puerto Ricans with the syndrome. Bailin and coworkers suggest that mutations in the adaptor-related code complex (termed AP-3) subunits may lead to some forms of HPS.[17] The AP-3 complex facilitates transport of vesicles from the trans-Golgi network and endosomal compartments. AP-3 interacts with tyrosine signals on proteins of lysosomes and other intracellular organelles.
Previous
 
 
Contributor Information and Disclosures
Author

Natalio J Izquierdo, MD Associate Professor, Medical Sciences Campus, University of Puerto Rico School of Medicine

Natalio J Izquierdo, MD is a member of the following medical societies: American Academy of Ophthalmology, Puerto Rico Medical Association, Pan-American Association of Ophthalmology, International Society for Genetic Eye Diseases and Retinoblastoma, Sociedad Puertorriquena de Oftalmologia

Disclosure: Nothing to disclose.

Coauthor(s)

William Townsend, MD Professor of Ophthalmology, Medical Sciences Campus, University of Puerto Rico School of Medicine

William Townsend, MD is a member of the following medical societies: American Academy of Ophthalmology, American Ophthalmological Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Simon K Law, MD, PharmD Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Glaucoma Society

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy, Sr, MD Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy, Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Additional Contributors

Andrew W Lawton, MD Neuro-Ophthalmology, Ochsner Health Services

Andrew W Lawton, MD is a member of the following medical societies: American Academy of Ophthalmology, Arkansas Medical Society, Southern Medical Association

Disclosure: Nothing to disclose.

Acknowledgements

Brian R Younge, MD Professor of Ophthalmology, Mayo Clinic School of Medicine

Brian R Younge, MD is a member of the following medical societies: American Medical Association, American Ophthalmological Society, and North American Neuro-Ophthalmology Society

Disclosure: Nothing to disclose.

References
  1. Carter BW. Hermansky-Pudlak syndrome complicated by pulmonary fibrosis. Proc (Bayl Univ Med Cent). 2012 Jan. 25(1):76-7. [Medline]. [Full Text].

  2. Walker M, Payne J, Wagner B, Vora A. Hermansky-Pudlak syndrome. Br J Haematol. 2007 Sep. 138(6):671. [Medline].

  3. Vincent LM, Adams D, Hess RA, et al. Hermansky-Pudlak syndrome type 1 in patients of Indian descent. Mol Genet Metab. 2009 Jul. 97(3):227-33. [Medline]. [Full Text].

  4. Spencer J, Rosengren S. Hermansky-Pudlak syndrome in pregnancy. Am J Perinatol. 2009 Oct. 26(9):617-9. [Medline].

  5. Hurford MT, Sebastiano C. Hermansky-pudlak syndrome: report of a case and review of the literature. Int J Clin Exp Pathol. 2008 Jan 1. 1(6):550-4. [Medline]. [Full Text].

  6. Suzuki T, Tomita Y. Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4. J Dermatol Sci. 2008 Jul. 51(1):1-9. [Medline].

  7. Carmona-Rivera C, Golas G, Hess RA, et al. Clinical, molecular, and cellular features of non-Puerto Rican Hermansky-Pudlak syndrome patients of Hispanic descent. J Invest Dermatol. 2011 Dec. 131(12):2394-400. [Medline]. [Full Text].

  8. Gradstein L, FitzGibbon EJ, Tsilou ET, Rubin BI, Huizing M, Gahl WA. Eye movement abnormalities in hermansky-pudlak syndrome. J AAPOS. 2005 Aug. 9(4):369-78. [Medline].

  9. Tang J, Tsilou E, Caruso RC, Rubin B, Gahl WA. Bilateral staphylomas in a patient with Hermansky-Pudlak syndrome. Retina. 2005 Jan. 25(1):99-100. [Medline].

  10. Chong GT, Farsiu S, Freedman SF, et al. Abnormal foveal morphology in ocular albinism imaged with spectral-domain optical coherence tomography. Arch Ophthalmol. 2009 Jan. 127(1):37-44. [Medline].

  11. Echenique I, Garcia Gonzralez JM, Echenique IA, et al. Hermansky Pudlak syndrome: an unusual form of procto-colitis. Bol Asoc Med P R. 2008 Jan-Mar. 100(1):76-9. [Medline].

  12. Lee AC, Poon KH, Lo WH, Wong LG. Chronic ulcerative gastroduodenitis as a first gastrointestinal manifestation of Hermansky-Pudlak syndrome in a 10-year-old child. World J Gastroenterol. 2008 May 14. 14(18):2939-41. [Medline].

  13. Kouklakis G, Efremidou EI, Papageorgiou MS, Pavlidou E, Manolas KJ, Liratzopoulos N. Complicated Crohn's-like colitis, associated with Hermansky-Pudlak syndrome, treated with Infliximab: a case report and brief review of the literature. J Med Case Rep. 2007 Dec 8. 1:176. [Medline]. [Full Text].

  14. Lee AC, Poon KH, Lo WH, Wong LG. Chronic ulcerative gastroduodenitis as a first gastrointestinal manifestation of Hermansky-Pudlak syndrome in a 10-year-old child. World J Gastroenterol. 2008 May 14. 14(18):2939-41. [Medline].

  15. Fukai K, Oh J, Frenk E, Almodovar C, Spritz RA. Linkage disequilibrium mapping of the gene for Hermansky-Pudlak syndrome to chromosome 10q23.1-q23.3. Hum Mol Genet. 1995 Sep. 4(9):1665-9. [Medline].

  16. Anikster Y, Huizing M, White J, Shevchenko YO, Fitzpatrick DL, Touchman JW, et al. Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet. 2001 Aug. 28(4):376-80. [Medline].

  17. Bailin T, Oh J, Feng GH, Fukai K, Spritz RA. Organization and nucleotide sequence of the human Hermansky-Pudlak syndrome (HPS) gene. J Invest Dermatol. 1997 Jun. 108(6):923-7. [Medline].

  18. Witkop CJ, Nunez Babcock M, Rao GH, et al. Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R. 1990 Aug. 82(8):333-9. [Medline].

  19. Jones ML, Murden SL, Bem D, et al. Rapid genetic diagnosis of heritable platelet function disorders with next-generation sequencing: proof-of-principle with Hermansky-Pudlak syndrome. J Thromb Haemost. 2012 Feb. 10(2):306-9. [Medline].

  20. Brantly M, Avila NA, Shotelersuk V, Lucero C, Huizing M, Gahl WA. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest. 2000 Jan. 117(1):129-36. [Medline].

  21. DellAngelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell. 1999 Jan. 3(1):11-21. [Medline].

  22. Hazelwood S, Shotelersuk V, Wildenberg SC, et al. Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome. Am J Hum Genet. 1997 Nov. 61(5):1088-94. [Medline]. [Full Text].

  23. Iwata F, Reed GF, Caruso RC, Kuehl EM, Gahl WA, Kaiser-Kupfer MI. Correlation of visual acuity and ocular pigmentation with the 16-bp duplication in the HPS-1 gene of Hermansky-Pudlak syndrome, a form of albinism. Ophthalmology. 2000 Apr. 107(4):783-9. [Medline].

  24. Izquierdo NJ, Townsend W, Hussels IE. Ocular findings in the Hermansky-Pudlak syndrome. Trans Am Ophthalmol Soc. 1995. 93:191-200; discussion 200-2. [Medline].

  25. Oh J, Bailin T, Fukai K. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet. 1996 Nov. 14(3):300-6. [Medline].

  26. Ray A, Ray S, Matthew JJ. Case Report : Hermansky Pudlak Syndrome (Presenting as late onset heavy Menstrual Bleeding). J Clin Diagn Res. September 2013. 7(9):2023-4. [Medline].

  27. Reynolds SP, Davies BH, Gibbs AR. Diffuse pulmonary fibrosis and the Hermansky-Pudlak syndrome: clinical course and postmortem findings. Thorax. 1994 Jun. 49(6):617-8. [Medline].

  28. Schachne JP, Glaser N, Lee SH, Kress Y, Fisher M. Hermansky-Pudlak syndrome: case report and clinicopathologic review. J Am Acad Dermatol. 1990 May. 22(5 Pt 2):926-32. [Medline].

  29. Schinella RA, Greco MA, Cobert BL, Denmark LW, Cox RP. Hermansky-Pudlak syndrome with granulomatous colitis. Ann Intern Med. 1980 Jan. 92(1):20-3. [Medline].

  30. Simon JW, Adams RJ, Calhoun JH, Shapiro SS, Ingerman CM. Ophthalmic manifestations of the Hermansky-Pudlak syndrome (oculocutaneous albinism and hemorrhagic diathesis). Am J Ophthalmol. 1982 Jan. 93(1):71-7. [Medline].

  31. Summers CG, Knobloch WH, Witkop CJ Jr, King RA. Hermansky-Pudlak syndrome. Ophthalmic findings. Ophthalmology. 1988 Apr. 95(4):545-54. [Medline].

  32. Toro J, Turner M, Gahl WA. Dermatologic manifestations of Hermansky-Pudlak syndrome in patients with and without a 16-base pair duplication in the HPS1 gene. Arch Dermatol. 1999 Jul. 135(7):774-80. [Medline].

  33. Van Dorp DB, Wijermans PW, Meire F, Vrensen G. The Hermansky-Pudlak syndrome. Variable reaction to 1-desamino-8D-arginine vasopressin for correction of the bleeding time. Ophthalmic Paediatr Genet. 1990 Sep. 11(3):237-44. [Medline].

  34. Wenham M, Grieve S, Cummins M, Jones ML, Booth S, Kilner R, et al. Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1. Haematologica. 2010 Feb. 95(2):333-7. [Medline]. [Full Text].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.